Walleye Capital’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,819
| Closed | -$147K | – | 1880 |
|
|
2024
Q4 | $147K | Buy |
+40,819
| New | +$147K | ﹤0.01% | 1597 |
|
|
2024
Q3 | – | Sell |
-39,976
| Closed | -$185K | – | 2526 |
|
|
2024
Q2 | $185K | Sell |
39,976
-12,328
| -24% | -$57K | ﹤0.01% | 1889 |
|
|
2024
Q1 | $427K | Buy |
+52,304
| New | +$427K | ﹤0.01% | 1464 |
|
|
2023
Q2 | – | Sell |
-29,792
| Closed | -$93.5K | – | 2183 |
|
|
2023
Q1 | $93.5K | Sell |
29,792
-12,945
| -30% | -$40.6K | ﹤0.01% | 1523 |
|
|
2022
Q4 | $252K | Sell |
42,737
-67,873
| -61% | -$400K | ﹤0.01% | 1264 |
|
|
2022
Q3 | $970K | Sell |
110,610
-203,656
| -65% | -$1.79M | 0.02% | 738 |
|
|
2022
Q2 | $2.37M | Buy |
+314,266
| New | +$2.37M | 0.07% | 308 |
|
|
2022
Q1 | – | Sell |
-81,720
| Closed | -$2.63M | – | 2241 |
|
|
2021
Q4 | $2.63M | Buy |
+81,720
| New | +$2.63M | 0.08% | 258 |
|